304 related articles for article (PubMed ID: 18490067)
1. Incorporating model uncertainty in cost-effectiveness analysis: a Bayesian model averaging approach.
Negrín MA; Vázquez-Polo FJ
J Health Econ; 2008 Sep; 27(5):1250-9. PubMed ID: 18490067
[TBL] [Abstract][Full Text] [Related]
2. Bayesian cost-effectiveness analysis with two measures of effectiveness: the cost-effectiveness acceptability plane.
Negrín MA; Vázquez-Polo FJ
Health Econ; 2006 Apr; 15(4):363-72. PubMed ID: 16259048
[TBL] [Abstract][Full Text] [Related]
3. Complementing the net benefit approach: a new framework for Bayesian cost-effectiveness analysis.
Hernández MA; Vázquez-Polo FJ; González-Torre FJ; Bas EM
Int J Technol Assess Health Care; 2009 Oct; 25(4):537-45. PubMed ID: 19845984
[TBL] [Abstract][Full Text] [Related]
4. A Bayesian model averaging approach for cost-effectiveness analyses.
Conigliani C; Tancredi A
Health Econ; 2009 Jul; 18(7):807-21. PubMed ID: 18792078
[TBL] [Abstract][Full Text] [Related]
5. Using covariates to reduce uncertainty in the economic evaluation of clinical trial data.
Vázquez-Polo FJ; Negrín Hernández MA; López-Valcárcel BG
Health Econ; 2005 Jun; 14(6):545-57. PubMed ID: 15497202
[TBL] [Abstract][Full Text] [Related]
6. Bayesian approaches to multiple sources of evidence and uncertainty in complex cost-effectiveness modelling.
Spiegelhalter DJ; Best NG
Stat Med; 2003 Dec; 22(23):3687-709. PubMed ID: 14652869
[TBL] [Abstract][Full Text] [Related]
7. Modeling the value for money of changing clinical practice change: a stochastic application in diabetes care.
Hoomans T; Abrams KR; Ament AJ; Evers SM; Severens JL
Med Care; 2009 Oct; 47(10):1053-61. PubMed ID: 19648827
[TBL] [Abstract][Full Text] [Related]
8. Bayesian estimation of cost-effectiveness from censored data.
Heitjan DF; Kim CY; Li H
Stat Med; 2004 Apr; 23(8):1297-309. PubMed ID: 15083484
[TBL] [Abstract][Full Text] [Related]
9. Impact of generic drug entry on cost-effectiveness analysis.
Shih YC; Han S; Cantor SB
Med Decis Making; 2005; 25(1):71-80. PubMed ID: 15673583
[TBL] [Abstract][Full Text] [Related]
10. Plant stanol esters are potentially cost-effective in the prevention of coronary heart disease in men: Bayesian modelling approach.
Martikainen JA; Ottelin AM; Kiviniemi V; Gylling H
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):265-72. PubMed ID: 17446806
[TBL] [Abstract][Full Text] [Related]
11. Bayesian regression models for cost-effectiveness analysis.
Polo FJ; Negrín M; Badía X; Roset M
Eur J Health Econ; 2005 Mar; 6(1):45-52. PubMed ID: 15517461
[TBL] [Abstract][Full Text] [Related]
12. Limitations of acceptability curves for presenting uncertainty in cost-effectiveness analysis.
Groot Koerkamp B; Hunink MG; Stijnen T; Hammitt JK; Kuntz KM; Weinstein MC
Med Decis Making; 2007; 27(2):101-11. PubMed ID: 17409361
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness acceptability curves--caveats quantified.
Jakubczyk M; Kamiński B
Health Econ; 2010 Aug; 19(8):955-63. PubMed ID: 19688780
[TBL] [Abstract][Full Text] [Related]
14. A Bayesian approach to net health benefits: an illustration and application to modeling HIV prevention.
Johnson-Masotti AP; Laud PW; Hoffmann RG; Hayat MJ; Pinkerton SD
Med Decis Making; 2004; 24(6):634-53. PubMed ID: 15534344
[TBL] [Abstract][Full Text] [Related]
15. Stochastic league tables: an application to diabetes interventions in the Netherlands.
Hutubessy RC; Niessen LW; Dijkstra RF; Casparie TF; Rutten FF
Health Econ; 2005 May; 14(5):445-55. PubMed ID: 15386648
[TBL] [Abstract][Full Text] [Related]
16. Risk aversion and uncertainty in cost-effectiveness analysis: the expected-utility, moment-generating function approach.
Elbasha EH
Health Econ; 2005 May; 14(5):457-70. PubMed ID: 15386661
[TBL] [Abstract][Full Text] [Related]
17. Bayesian estimation, simulation and uncertainty analysis: the cost-effectiveness of ganciclovir prophylaxis in liver transplantation.
Vanness DJ; Kim WR
Health Econ; 2002 Sep; 11(6):551-66. PubMed ID: 12203757
[TBL] [Abstract][Full Text] [Related]
18. Using costs in cost-effectiveness models for chronic diseases: lessons from diabetes.
Hoerger TJ
Med Care; 2009 Jul; 47(7 Suppl 1):S21-7. PubMed ID: 19536014
[TBL] [Abstract][Full Text] [Related]
19. Bayesian cost-effectiveness analysis from clinical trial data.
O'Hagan A; Stevens JW; Montmartin J
Stat Med; 2001 Mar; 20(5):733-53. PubMed ID: 11241573
[TBL] [Abstract][Full Text] [Related]
20. The role of cost effectiveness analysis in health care evaluation.
Atherly A; Culler SD; Becker ER
Q J Nucl Med; 2000 Jun; 44(2):112-20. PubMed ID: 10967622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
